Vaxcyte's market cap is currently ―. The company's EPS TTM is $-4.205; its P/E ratio is -15.99; Vaxcyte is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-1.13. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -92.66M	$ -68.34M	$ -70.86M	$ -84.68M	$ -57.92M
EBITDA	$ -104.76M	$ -77.78M	$ -71.56M	$ -82.78M	$ -55.56M
Net Income Common Stockholders	$ -92.66M	$ -68.34M	$ -60.46M	$ -78.05M	$ -57.92M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.27B	$ 1.29B	$ 822.04M	$ 931.38M	$ 362.23M
Total Assets	$ 1.50B	$ 1.50B	$ 1.01B	$ 1.01B	$ 412.06M
Total Debt	$ 13.81M	$ 15.21M	$ 16.59M	$ 17.94M	$ 19.78M
Net Debt	$ -1.25B	$ -1.27B	$ -805.45M	$ -913.43M	$ -342.44M
Total Liabilities	$ 93.34M	$ 69.44M	$ 63.39M	$ 52.56M	$ 52.75M
Stockholders Equity	$ 1.40B	$ 1.43B	$ 944.77M	$ 953.61M	$ 359.31M
Cash Flow	-
Free Cash Flow	$ -64.89M	$ -60.60M	$ -53.30M	$ -66.37M	$ -39.39M
Operating Cash Flow	$ -57.55M	$ -62.74M	$ -47.69M	$ -65.22M	$ -38.55M
Investing Cash Flow	$ 22.28M	$ -333.56M	$ -448.10M	$ -35.95M	$ 34.71M
Financing Cash Flow	$ 48.55M	$ 546.97M	$ 41.56M	$ 656.63M	$ 44.02M

Currency in USD

Vaxcyte Earnings and Revenue History

Income Statement >

Vaxcyte Debt to Assets

Balance Sheet >

Vaxcyte Cash Flow

Cash Flow >

Vaxcyte Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing